Examkin

Question

Difficulty: HardRheumatology and Immunology

A 29-year-old woman with a 5-year history of systemic lupus erythematosus (SLE), previously well-controlled on hydroxychloroquine, presents with new-onset bilateral lower extremity edema, new hypertension (150/92 mm Hg), and an elevated serum creatinine of 1.4 mg/dL. Assuming no contraindications or delays in procedural availability, arrange the following steps in the most appropriate chronological sequence for the standard evaluation and management of this patient's new clinical presentation.

  1. 1Perform a urinalysis with microscopy and quantify proteinuria with a spot urine protein-to-creatinine ratio.
  2. 2Perform an ultrasound-guided percutaneous renal biopsy to determine the histologic class of the nephropathy.
  3. 3Initiate induction immunosuppressive therapy with high-dose glucocorticoids and either mycophenolate mofetil or cyclophosphamide.
  4. 4Transition to lower-dose maintenance immunosuppression, typically with mycophenolate mofetil or azathioprine, after achieving clinical response.

Answer

The correct sequence for evaluating and managing suspected new-onset lupus nephritis is: 1) Urinalysis and protein quantification, 2) Percutaneous renal biopsy, 3) Induction immunosuppression, and 4) Maintenance immunosuppression.
The correct chronological sequence perfectly follows the KDIGO and ACR guidelines for lupus nephritis: the diagnosis must first be confirmed non-invasively, then staged invasively to determine the appropriate treatment intensity. Once the class is known, the disease is aggressively treated to induce remission, and finally maintained with a safer, long-term immunomodulatory regimen.

Step-by-Step Solution

1
Identify the clinical presentation as highly suspicious for lupus nephritis.
The patient's new-onset edema, hypertension, and elevated creatinine strongly suggest active renal involvement in the setting of her known SLE.
Recognizing the presentation dictates the urgent need for a specialized renal workup to prevent irreversible kidney damage.
2
Select the initial non-invasive diagnostic tests.
Urinalysis with microscopy and a spot urine protein-to-creatinine ratio.
These tests confirm the presence of active urinary sediment (e.g., red blood cell casts) and quantify the degree of proteinuria, firmly establishing the clinical presence of nephritis before invasive procedures.
3
Determine the necessary invasive diagnostic step prior to aggressive treatment.
Percutaneous renal biopsy.
Lupus nephritis has six distinct histologic classes. Because treatment varies drastically depending on the class (ranging from minimal targeted therapy for Class II to highly toxic cytotoxic therapy for Class IV), a biopsy is the standard of care before initiating heavy immunosuppression.
4
Determine the sequence of pharmacologic management for severe lupus nephritis.
Induction therapy followed subsequently by maintenance therapy.
If the biopsy reveals proliferative (Class III/IV) nephritis, standard protocol involves intense 'induction' (high-dose steroids combined with mycophenolate or cyclophosphamide) for several months to achieve remission, followed by step-down 'maintenance' therapy to sustain that remission safely.

Key Concept

The algorithmic evaluation of suspected lupus nephritis requires confirming active renal involvement non-invasively (urinalysis/proteinuria), followed strictly by a renal biopsy to determine the histologic class before initiating class-specific induction and subsequent maintenance immunosuppressive therapy.
Estimated Time:1m 30s
Rate this question

Topics

Rheumatology and Immunology

More questions from this topic